Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Surrozen (SRZNW) EBITDA (2023 - 2025)

Historic EBITDA for Surrozen (SRZNW) over the last 3 years, with Q3 2025 value amounting to -$10.9 million.

  • Surrozen's EBITDA fell 65906.56% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.5 million, marking a year-over-year decrease of 10153.54%. This contributed to the annual value of -$63.6 million for FY2024, which is 4851.05% down from last year.
  • Surrozen's EBITDA amounted to -$10.9 million in Q3 2025, which was down 65906.56% from -$9.0 million recorded in Q2 2025.
  • In the past 5 years, Surrozen's EBITDA ranged from a high of -$1.4 million in Q3 2024 and a low of -$28.0 million during Q4 2024
  • Over the past 3 years, Surrozen's median EBITDA value was -$9.1 million (recorded in 2024), while the average stood at -$10.7 million.
  • In the last 5 years, Surrozen's EBITDA surged by 8627.62% in 2024 and then tumbled by 65906.56% in 2025.
  • Quarter analysis of 3 years shows Surrozen's EBITDA stood at -$8.9 million in 2023, then tumbled by 214.55% to -$28.0 million in 2024, then soared by 61.18% to -$10.9 million in 2025.
  • Its EBITDA stands at -$10.9 million for Q3 2025, versus -$9.0 million for Q2 2025 and -$9.6 million for Q1 2025.